Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 11 studies | 42% ± 26% | |
endothelial cell | 9 studies | 27% ± 10% | |
GABAergic neuron | 7 studies | 41% ± 22% | |
mast cell | 6 studies | 23% ± 6% | |
neuron | 5 studies | 30% ± 7% | |
macrophage | 5 studies | 20% ± 2% | |
interneuron | 5 studies | 36% ± 17% | |
microglial cell | 4 studies | 22% ± 4% | |
retinal ganglion cell | 4 studies | 34% ± 15% | |
epithelial cell | 4 studies | 29% ± 3% | |
astrocyte | 4 studies | 28% ± 10% | |
oligodendrocyte precursor cell | 4 studies | 24% ± 5% | |
endothelial cell of lymphatic vessel | 4 studies | 19% ± 0% | |
GABAergic interneuron | 3 studies | 22% ± 4% | |
granule cell | 3 studies | 20% ± 3% | |
ciliated cell | 3 studies | 18% ± 1% | |
basal cell | 3 studies | 26% ± 2% | |
oligodendrocyte | 3 studies | 28% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 12 studies | 31% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2007.85 | 1445 / 1445 | 100% | 32.70 | 183 / 183 |
brain | 100% | 2552.37 | 2638 / 2642 | 100% | 34.45 | 705 / 705 |
bladder | 100% | 2016.10 | 21 / 21 | 100% | 31.75 | 503 / 504 |
prostate | 100% | 1297.27 | 245 / 245 | 100% | 23.93 | 501 / 502 |
uterus | 100% | 1596.19 | 170 / 170 | 100% | 37.00 | 458 / 459 |
breast | 100% | 1377.72 | 459 / 459 | 100% | 33.36 | 1115 / 1118 |
lung | 100% | 1281.96 | 576 / 578 | 100% | 35.55 | 1155 / 1155 |
stomach | 100% | 1156.44 | 359 / 359 | 100% | 25.96 | 285 / 286 |
intestine | 100% | 1678.57 | 966 / 966 | 100% | 28.49 | 525 / 527 |
ovary | 100% | 1209.48 | 180 / 180 | 100% | 19.09 | 428 / 430 |
thymus | 100% | 1093.21 | 653 / 653 | 99% | 26.17 | 600 / 605 |
kidney | 100% | 935.11 | 89 / 89 | 98% | 21.93 | 886 / 901 |
skin | 100% | 1542.23 | 1807 / 1809 | 97% | 28.19 | 459 / 472 |
adrenal gland | 100% | 1062.54 | 257 / 258 | 97% | 23.64 | 224 / 230 |
pancreas | 93% | 556.49 | 305 / 328 | 99% | 33.10 | 176 / 178 |
liver | 82% | 406.12 | 186 / 226 | 88% | 11.05 | 357 / 406 |
adipose | 100% | 1448.76 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1976.74 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 22.79 | 29 / 29 |
spleen | 100% | 1233.48 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 40.25 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 20.35 | 1 / 1 |
muscle | 99% | 903.25 | 796 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 938.69 | 837 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 16.21 | 73 / 80 |
peripheral blood | 76% | 1105.82 | 707 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042327 | Biological process | positive regulation of phosphorylation |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0044342 | Biological process | type B pancreatic cell proliferation |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0001650 | Cellular component | fibrillar center |
GO_0005515 | Molecular function | protein binding |
Gene name | BTBD10 |
Protein name | BTBD10 protein BTB domain containing 10 BTB/POZ domain-containing protein 10 (Glucose metabolism-related protein 1) BTB (POZ) domain containing 10, isoform CRA_a (Epididymis secretory sperm binding protein) (GMRP1) BTB (POZ) domain containing 10, isoform CRA_c (BTB domain containing 10) (cDNA FLJ58599, highly similar to BTB/POZ domain-containing protein 10) |
Synonyms | hCG_23555 GMRP1 |
Description | FUNCTION: Plays a major role as an activator of AKT family members by inhibiting PPP2CA-mediated dephosphorylation, thereby keeping AKTs activated. Plays a role in preventing motor neuronal death and accelerating the growth of pancreatic beta cells. . |
Accessions | ENST00000526841.1 B7Z503 E9PKU9 ENST00000278174.10 [Q9BSF8-1] ENST00000530907.5 [Q9BSF8-2] ENST00000527102.6 Q9BSF8 E9PPD8 Q7L2U6 E9PN21 Q6P5W1 E9PKM7 ENST00000528120.5 ENST00000529708.5 D3DQW7 ENST00000525108.5 |